-
Glenmark readies new products to counter global headwinds
-
Marginal fall in Zydus Cadila’s profit in March quarter
-
Piramal Acquires 4 Pfizer Brands
-
Aurobindo gets USFDA Nod for Generic Migraine Drug
-
Pfizer restricts sale of its drugs used in executions
-
Cadila Health to raise UP to Rs 18,500 crores
-
Glen mark Pharma:A lot riding on US market in fiscal 2017
-
Medicines had expired by the time we got regulator’s alert: Abbott
-
New Products will drive growth at Dr Reddy’s
-
More pen Labs Global Leader in Drug to Fight Asthma